FDA 483 - Neocis, Inc. - August 11, 2022

Neocis, Inc. in Miami, FL, a medical device manufacturer, received three observations during an FDA inspection. The firm was cited for inadequate procedures for corrective and preventive actions, deficiencies in calibration procedures, and a lack of documented personnel training. These findings indicate significant gaps in the firm's quality system documentation and implementation.